Director Omnibus Decision – 12 IPRsJune 12, 2026
Notice of Decisions on Institution — 2026-06-12
Patent Trial and Appeal Board
Total Proceedings
12
in this notice
Total Denied
7
discretionary + merits
Total Instituted
5
trial granted
Grant Rate
42%
58% denial rate
Trial Instituted· 5 proceedings
IPR2026-00180PGR2026-00020IPR2026-00184PGR2026-00017IPR2026-00195
Discretionary Denial· 5 proceedings
IPR2026-00240IPR2026-00241IPR2026-00242IPR2026-00243IPR2026-00239
Institution Denied· 2 proceedings
IPR2026-00175IPR2026-00183
Note
The USPTO Director issued an omnibus institution notice covering multiple proceedings. Written opinions may follow for selected cases.
- PTAB Director Review · Oct. 8, 2026Notice of Decisions on Institution — 2026-10-08
- PTAB Director Review · Sept. 24, 2026Biocon Biologics Limited et al. v. Regeneron Pharmaceuticals, Inc.
- PTAB Director Review · Sept. 23, 2026Notice of Decisions on Institution — 2026-09-23
- PTAB Director Review · Sept. 23, 2026Nearmap US, Inc. v. Eagle View Technologies, Inc.
- PTAB Director Review · Aug. 25, 2026Aesthetic Management Partners, LLC and Aesthetic Management Partners, Inc. v. HydraFacial LLC